Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake
Kosuke Kaji; Norihisa Nishimura; Kenichiro Seki; Shinya Sato; Soichiro Saikawa; Keisuke Nakanishi; Masanori Furukawa; Hideto Kawaratani; Mitsuteru Kitade; Kei Moriya; Tadashi Namisaki; Hitoshi Yoshiji
Author Information: Third Department of Internal Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.